Search results for "Continuation"

showing 10 items of 276 documents

Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literature.

2018

Objectives To review the available evidence concerning the possibility of discontinuing and/or tapering the dosage of TNF inhibitors (TNFi) in RA patients experiencing clinical remission or low disease activity. Methods A systematic review of the literature concerning the low dosage and discontinuation of TNFi in disease-controlled RA patients was performed by evaluation of reports published in indexed international journals (Medline via PubMed, EMBASE), in the time frame from 8 April 2013 to 15 January 2016. Results We analysed the literature evaluating the efficacy and the safety of two different strategies using TNFi, decreasing dosage or discontinuation, in patients experiencing clinica…

Drugmedicine.medical_specialtymedia_common.quotation_subjectMEDLINEArthritisEtanerceptDose-Response RelationshipArthritis Rheumatoid03 medical and health sciences0302 clinical medicineRheumatologyRheumatoidInternal medicinemedicineAdalimumabHumansPharmacology (medical)030212 general & internal medicinemedia_common030203 arthritis & rheumatologyDose-Response Relationship Drugbusiness.industryTumor Necrosis Factor-alphaArthritisRemission Inductionmedicine.diseaseRheumatologyAntirheumatic Agents; Arthritis Rheumatoid; Dose-Response Relationship Drug; Humans; Remission Induction; Tumor Necrosis Factor-alpha; Rheumatology; Pharmacology (medical)DiscontinuationRheumatoid arthritisAntirheumatic AgentsDrugbusinessmedicine.drugRheumatology (Oxford, England)
researchProduct

Cautionnement. Plan de continuation, Délai consenti par un créancier dans le cadre de l'article 24 de la loi de 1985, Impossibilité pour la caution d…

1992

International audience; (Com. 28 mai 1991, Casas c/ Banque Nationale de Paris)

Débiteur principal[SHS.DROIT]Humanities and Social Sciences/LawRedressement et liquidation judiciaires[SHS.DROIT] Humanities and Social Sciences/LawDélai consenti au débiteurPlan de continuationCAUTIONNEMENT
researchProduct

Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.

2019

Abstract Background Dual inhibition of the mitogen-activated protein kinase pathway with BRAF/MEK inhibitor (BRAFi/MEKi) therapy is a standard treatment for BRAFV600-mutant metastatic melanoma and has historically been associated with grade III pyrexia or photosensitivity depending on the combination used. The objective of this study was to fully describe adverse events from the COLUMBUS study evaluating the most recent BRAF/MEK inhibitor combination encorafenib+binimetinib. Patients and methods Patients with locally advanced, unresectable or metastatic BRAFV600-mutant melanoma were randomised to receive encorafenib 450 mg once daily plus binimetinib 45 mg twice daily, encorafenib 300 mg on…

Encorafenib0301 basic medicineOncologyMaleCancer ResearchSkin NeoplasmsBinimetinib; Encorafenib; Melanoma; Safety; Vemurafenib;MedizinBinimetinibchemistry.chemical_compound0302 clinical medicineAntineoplastic Combined Chemotherapy Protocols1306 Cancer ResearchVemurafenibMelanomaFatigueeducation.field_of_studySulfonamidesMEK inhibitorMelanomaStandard treatmentIncidence10177 Dermatology ClinicBinimetinibNauseaMiddle AgedOncology030220 oncology & carcinogenesis2730 OncologyFemaleSafetyMitogen-Activated Protein Kinasesmedicine.drugProto-Oncogene Proteins B-rafmedicine.medical_specialtyVomitingPopulation610 Medicine & health03 medical and health sciencesInternal medicinemedicineHumanseducationAdverse effectProtein Kinase Inhibitorsbusiness.industrymedicine.diseaseDiscontinuation030104 developmental biologychemistryVemurafenibMutationBenzimidazolesCarbamatesbusinessEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Unique continuation of the normal operator of the x-ray transform and applications in geophysics

2020

We show that the normal operator of the X-ray transform in $\mathbb{R}^d$, $d\geq 2$, has a unique continuation property in the class of compactly supported distributions. This immediately implies uniqueness for the X-ray tomography problem with partial data and generalizes some earlier results to higher dimensions. Our proof also gives a unique continuation property for certain Riesz potentials in the space of rapidly decreasing distributions. We present applications to local and global seismology. These include linearized travel time tomography with half-local data and global tomography based on shear wave splitting in a weakly anisotropic elastic medium.

FOS: Physical sciencesx-ray transformSpace (mathematics)01 natural sciencesTheoretical Computer SciencePhysics - GeophysicsContinuationtomografiaClassical Analysis and ODEs (math.CA)FOS: MathematicsNormal operatorUniqueness0101 mathematicsAnisotropyMathematical PhysicsMathematicsX-ray transformgeophysicsApplied Mathematics010102 general mathematicsMathematical analysisgeofysiikkaShear wave splittingInverse problemFunctional Analysis (math.FA)Geophysics (physics.geo-ph)Computer Science ApplicationsMathematics - Functional Analysis010101 applied mathematicsMathematics - Classical Analysis and ODEsSignal ProcessingInverse Problems
researchProduct

A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medicat…

2021

Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeutic option for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability is warranted. In this multicenter prospective, observational, postauthorization safety study conducted in Italy and Spain, postmenopausal women (PMW) with osteoporosis (naïve to bisphosphonates) were treated weekly with a buffered soluble alendronate 70 mg effervescent (ALN-EFF) tablet (Binosto®) and followed for 12 ± 3 months. Information was collected on adverse events (AEs), medication errors, persistence, and compliance using the Morisky-Green questi…

GASTROINTESTINAL ADVERSE EVENTSmedicine.medical_specialtyAgingNauseaEndocrinology Diabetes and MetabolismOsteoporosisDiseases of the musculoskeletal systemOSTEOPOROSISInternal medicineparasitic diseasesmedicineClinical endpointOrthopedics and Sports MedicineCumulative incidenceAdverse effectALENDRONATEOrthopedic surgerybusiness.industryalendronate; effervescent; gastrointestinal adverse events; osteoporosis; postmenopausal womenEvaluation of treatments and therapeutic interventionsEFFERVESCENTOriginal Articlesmedicine.diseaseConfidence intervalDiscontinuationTolerabilityPOSTMENOPAUSAL WOMENRC925-9356.1 PharmaceuticalsOsteoporosisOriginal ArticlePatient Safetymedicine.symptombusinessDigestive DiseasesRD701-811JBMR Plus
researchProduct

Moderately close Neumann inclusions for the Poisson equation

2016

We investigate the behavior of the solution of a mixed problem for the Poisson equation in a domain with two moderately close holes. If ϱ1 and ϱ2 are two positive parameters, we define a perforated domain Ω(ϱ1,ϱ2) by making two small perforations in an open set: the size of the perforations is ϱ1ϱ2, while the distance of the cavities is proportional to ϱ1. Then, if r∗ is small enough, we analyze the behavior of the solution for (ϱ1,ϱ2) close to the degenerate pair (0,r∗). Copyright © 2016 John Wiley & Sons, Ltd.

General Mathematics010102 general mathematicsMathematical analysisGeneral Engineeringmixed problem; moderately close holes; Poisson equation; real analytic continuation in Banach space; singularly perturbed perforated domain; Mathematics (all); Engineering (all)Poisson equation01 natural sciences010101 applied mathematicsmixed problemsingularly perturbed perforated domainEngineering (all)Settore MAT/05 - Analisi MatematicaMathematics (all)0101 mathematicsPoisson's equationmoderately close holesMathematicsreal analytic continuation in Banach space
researchProduct

Recovery of time-dependent coefficients from boundary data for hyperbolic equations

2019

We study uniqueness of the recovery of a time-dependent magnetic vector-valued potential and an electric scalar-valued potential on a Riemannian manifold from the knowledge of the Dirichlet to Neumann map of a hyperbolic equation. The Cauchy data is observed on time-like parts of the space-time boundary and uniqueness is proved up to the natural gauge for the problem. The proof is based on Gaussian beams and inversion of the light ray transform on Lorentzian manifolds under the assumptions that the Lorentzian manifold is a product of a Riemannian manifold with a time interval and that the geodesic ray transform is invertible on the Riemannian manifold.

GeodesicDirichlet-to-Neumann maplight ray transformmagnetic potentialBoundary (topology)CALDERON PROBLEM01 natural sciencesGaussian beamMathematics - Analysis of PDEsFOS: Mathematics111 Mathematics[MATH.MATH-AP]Mathematics [math]/Analysis of PDEs [math.AP]Uniqueness0101 mathematicsMathematics::Symplectic GeometryMathematical PhysicsMathematicsX-ray transformSTABILITYinverse problemsMathematical analysisStatistical and Nonlinear PhysicsRiemannian manifoldX-RAY TRANSFORMWave equationMathematics::Geometric TopologyManifoldTENSOR-FIELDS010101 applied mathematicsUNIQUE CONTINUATIONGeometry and TopologyMathematics::Differential GeometryWAVE-EQUATIONSHyperbolic partial differential equationAnalysis of PDEs (math.AP)
researchProduct

Correlation at Low Temperature: II. Asymptotics

2004

The present paper is a continuation of ref. 4, where the truncated two-point correlation function for a class of lattice spin systems was proved to have exponential decay at low temperature, under a weak coupling assumption. In this paper we compute the asymptotics of the correlation function as the temperature goes to zero. This paper thus extends ref. 3 in two directions: The Hamiltonian function is allowed to have several local minima other than a unique global minimum, and we do not require translation invariance of the Hamiltonian function. We are in particular able to handle spin systems on a general lattice.

Hamiltonian mechanicsMathematical analysisCrystal systemStatistical and Nonlinear PhysicsCorrelationMaxima and minimaContinuationsymbols.namesakeLattice (order)symbolsExponential decayLaplace operatorMathematical PhysicsMathematicsMathematical physicsJournal of Statistical Physics
researchProduct

Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome

2011

Evans Syndrome is a rare autoimmune disease consisting of hemolytic anemia, thrombocytopenia and/or neutropenia. It may be associated with other autoimmune or lymphoproliferative diseases. Its course can be extremely serious and, rarely, even life-threatening

Hemolytic anemiaVincristinePediatricsmedicine.medical_specialtyEvans syndromeoutcome.CyclophosphamideEvans’ syndrome Cyclosporine Mycophenolate mofetil Treatment Outcomelcsh:MedicineCase ReportNeutropeniaPediatricshemic and lymphatic diseasesmedicineevans syndromeOutcomeAutoimmune diseasebusiness.industryMycophenolate mofetillcsh:Rlcsh:RJ1-570lcsh:PediatricsEvans’ syndromemedicine.diseaseDiscontinuationTreatmentImmunologyCyclosporineRituximabbusinessmedicine.drugPediatric Reports
researchProduct

A construction of Frobenius manifolds from stability conditions

2018

A finite quiver $Q$ without loops or 2-cycles defines a 3CY triangulated category $D(Q)$ and a finite heart $A(Q)$. We show that if $Q$ satisfies some (strong) conditions then the space of stability conditions $Stab(A(Q))$ supported on this heart admits a natural family of semisimple Frobenius manifold structures, constructed using the invariants counting semistable objects in $D(Q)$. In the case of $A_n$ evaluating the family at a special point we recover a branch of the Saito Frobenius structure of the $A_n$ singularity $y^2 = x^{n+1}$. We give examples where applying the construction to each mutation of $Q$ and evaluating the families at a special point yields a different branch of the m…

High Energy Physics - TheoryMathematics - Differential GeometryFrobenius manifoldPure mathematics010308 nuclear & particles physicsTriangulated categoryGeneral MathematicsAnalytic continuation010102 general mathematicsQuiverStructure (category theory)FOS: Physical sciencesSpace (mathematics)01 natural sciencesMathematics - Algebraic GeometrySingularityHigh Energy Physics - Theory (hep-th)Differential Geometry (math.DG)0103 physical sciencesMutation (knot theory)FOS: MathematicsSettore MAT/03 - Geometria0101 mathematicsAlgebraic Geometry (math.AG)Mathematics
researchProduct